PharmaShots | Incisive News in 3 Shots

Subscribe Now

Alopecia Areata

Pfizer Reports Results of Ritlecitinib in P-IIb/III Trial for the Treatment of Alopecia Areata

Pfizer Reports Results of Ritlecitinib in P-IIb/III Trial for the Treatment of Alopecia Areata

August 5, 2021

Concert's CTP-543 Receives the US FDA's Breakthrough Therapy Designation to Treat Alopecia Areata

Concert's CTP-543 Receives the US FDA's Breakthrough Therapy Designation to Treat Alopecia Areata

July 8, 2020

Eli Lilly and Incyte's Olumiant (baricitinib) Receives the US FDA's Breakthrough Therapy Designation for Alopecia Areata

Eli Lilly and Incyte's Olumiant (baricitinib) Receives the US FDA's Breakthrough Therapy Designation for Alopecia Areata

March 16, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us